- Home
- NVNO vs ATRA Comparison
NVNO vs ATRA Comparison
Compare NVNO & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVNO
- ATRA
- Stock Information
- Founded
- NVNO 1987
- ATRA 2012
- Country
- NVNO United States
- ATRA United States
- Employees
- NVNO N/A
- ATRA N/A
- Industry
- NVNO Medical/Dental Instruments
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NVNO Health Care
- ATRA Health Care
- Exchange
- NVNO Nasdaq
- ATRA Nasdaq
- Market Cap
- NVNO 41.0M
- ATRA 40.1M
- IPO Year
- NVNO N/A
- ATRA 2014
- Fundamental
- Price
- NVNO $3.51
- ATRA $8.00
- Analyst Decision
- NVNO
- ATRA Buy
- Analyst Count
- NVNO 0
- ATRA 5
- Target Price
- NVNO N/A
- ATRA $17.75
- AVG Volume (30 Days)
- NVNO 80.1K
- ATRA 78.7K
- Earning Date
- NVNO 07-30-2025
- ATRA 05-15-2025
- Dividend Yield
- NVNO N/A
- ATRA N/A
- EPS Growth
- NVNO N/A
- ATRA N/A
- EPS
- NVNO N/A
- ATRA N/A
- Revenue
- NVNO N/A
- ATRA $199,732,000.00
- Revenue This Year
- NVNO N/A
- ATRA N/A
- Revenue Next Year
- NVNO $409.09
- ATRA N/A
- P/E Ratio
- NVNO N/A
- ATRA N/A
- Revenue Growth
- NVNO N/A
- ATRA 475.53
- 52 Week Low
- NVNO $2.03
- ATRA $5.01
- 52 Week High
- NVNO $6.48
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- NVNO 52.54
- ATRA 61.05
- Support Level
- NVNO $3.26
- ATRA $7.44
- Resistance Level
- NVNO $3.81
- ATRA $8.10
- Average True Range (ATR)
- NVNO 0.26
- ATRA 0.53
- MACD
- NVNO -0.04
- ATRA 0.09
- Stochastic Oscillator
- NVNO 33.78
- ATRA 92.28
About NVNO enVVeno Medical Corporation
enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).